Quarterly report · Q1
4361.TEDINET S100T7MO
Period2023-12-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2023-12-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥8.6bn | 2022-12-01 → 2023-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2022-12-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥68m | 2023-12-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥47m | 2022-12-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥67m | 2023-12-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥345m | 2022-12-01 → 2023-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46m | 2022-12-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥67m | 2023-12-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥46m | 2022-12-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥50m | 2023-12-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥256m | 2022-12-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥41m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥50m | 2023-12-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥41m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥8.1bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥8.2bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.4bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2023-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.6bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥2.6bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.4bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥906m | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2023-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥40.79 | 2023-12-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.88 | 2022-12-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.77 | 2022-12-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.5% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.6% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.1% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2023-12-01 → 2024-02-29 | ¥2.0bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2023-12-01 → 2024-02-29 | ¥2.0bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2023-12-01 → 2024-02-29 | ¥60m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue | 2023-12-01 → 2024-02-29 | ¥10m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue external | 2023-12-01 → 2024-02-29 | ¥10m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | segment profit | 2023-12-01 → 2024-02-29 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-02-29 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-02-29 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-02-29 | ¥68m |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2022-12-01 → 2023-02-28 | ¥39m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | segment profit | 2022-12-01 → 2023-02-28 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-02-28 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-02-28 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-02-28 | ¥47m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 333
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)海南監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)秋 葉 陽 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)米 川 博 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2051990000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 1999928000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 8610396000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 45971000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 66975000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 344577000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 41118000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 49659000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 255526000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 46680000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 48726000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 287950000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 2397153000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 2626277000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 2638424000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 8236168000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 8074939000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 8340594000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 33.77 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 40.79 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 209.88 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.291 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.325 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.316 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1220000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1220000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1220000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1220000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 2500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1213600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 12136 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 3900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 1220000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 12136 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 2500 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 2500 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0020 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |